down arrow

Nova Leap Health Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA66980G1090
  • TSX: NLH
CAD
0.52
-0.02 (-3.7%)

Sep 22

TSX

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
WELL Health Technologies Corp.
Nova Leap Health Corp.
CareRx Corp.
dentalcorp Holdings Ltd.
CloudMD Software & Services, Inc.
HealWELL AI, Inc.
Numinus Wellness, Inc.
BioMark Diagnostics, Inc.
Telo Genomics Corp.
Akumin, Inc.
Gemina Laboratories Ltd.

Why is Nova Leap Health Corp. ?

1
Poor long term growth as Operating profit has grown by an annual rate 30.40% of over the last 5 years
2
Flat results in Mar 26
  • NET PROFIT(HY) At CAD 0.38 MM has Grown at -70.66%
  • INTEREST(HY) At CAD 0.22 MM has Grown at 20.71%
3
With ROE of 1.42%, it has a expensive valuation with a 1.34 Price to Book Value
  • Over the past year, while the stock has generated a return of 65.22%, its profits have fallen by -75.2%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Nova Leap Health Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Nova Leap Health Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Nova Leap Health Corp.
52.94%
0.13
76.60%
S&P/TSX 60
20.36%
2.23
12.57%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
13.78%
EBIT Growth (5y)
30.40%
EBIT to Interest (avg)
0.51
Debt to EBITDA (avg)
0.62
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.38
Tax Ratio
27.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.50%
ROE (avg)
2.19%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
1.34
EV to EBIT
20.07
EV to EBITDA
12.59
EV to Capital Employed
1.33
EV to Sales
0.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.64%
ROE (Latest)
1.42%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -2.24% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 18.19 times

NET SALES(Q)

Highest at CAD 13 MM

OPERATING PROFIT(Q)

Highest at CAD 1.29 MM

OPERATING PROFIT MARGIN(Q)

Highest at 9.94 %

PRE-TAX PROFIT(Q)

Highest at CAD 1.26 MM

NET PROFIT(Q)

Highest at CAD 0.93 MM

EPS(Q)

Highest at CAD 0.01

-1What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at 15.51 %

Here's what is working for Nova Leap Health Corp.

Pre-Tax Profit
At CAD 1.26 MM has Grown at 672.19%
over average net sales of the previous four periods of CAD 0.16 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CAD MM)

Net Profit
At CAD 0.93 MM has Grown at 878.86%
over average net sales of the previous four periods of CAD 0.09 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CAD MM)

Net Sales
Highest at CAD 13 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CAD MM)

Operating Profit
Highest at CAD 1.29 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CAD MM)

Operating Profit Margin
Highest at 9.94 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at CAD 1.26 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Net Profit
Highest at CAD 0.93 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CAD MM)

EPS
Highest at CAD 0.01
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CAD)

Debtors Turnover Ratio
Highest at 18.19 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -2.24% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nova Leap Health Corp.

Debt-Equity Ratio
Highest at 15.51 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Footer loading